Advertisement
Grayscale Avalanche Trust ETF Common Units of Fractional Undivided Beneficial Interest

Stay Updated with the Latest Grayscale Avalanche Trust ETF Common Units of Fractional Undivided Beneficial Interest GAVA News in Real Time

Find GAVA news now at Meyka AI. Stay informed with the latest Grayscale Avalanche Trust ETF Common Units of Fractional Undivided Beneficial Interest stocks updates, including price news, market analysis, and expert insights.

GAVANASDAQ
Financial ServicesAsset Management - Cryptocurrency
$16.31
$0.86(5.60%)
U.S. Market is Open · 12:02
Advertisement
Nasdaq Composite Jumps 1.3% as Chip Rally Offsets Iran Tensions on July 9
📅 in about 5 hours

Nasdaq Composite Jumps 1.3% as Chip Rally Offsets Iran Tensions on July 9

Nasdaq Composite gains 1.3% to 26,206.89 on July 9 as chip stocks rally. Micron jumps 4.5% after $250B U.S. investment plan. Oil prices fall as Iran tensions ease.

Read more 12
BAE Systems Explores AI Combat Control for Typhoon Fighter Jets
📅 in about 5 hours

BAE Systems Explores AI Combat Control for Typhoon Fighter Jets

BAE Systems tests new cockpit system allowing Eurofighter Typhoon pilots to command multiple uncrewed combat drones with minimal workload increase, advancing collaborative air warfare.

Read more 12
STIKO Drops Routine COVID Boosters for Healthy Adults Under 75—July 10
📅 in about 2 hours

STIKO Drops Routine COVID Boosters for Healthy Adults Under 75—July 10

STIKO ends COVID booster recommendation for healthy German adults under 75. Over 95% now have hybrid immunity. Annual shots now only for those 75+, healthcare workers, and at-risk groups.

Read more 12
Tencent (HK:0700) in Talks to Become Largest Shareholder in AI Startup Manus at $2 Billion Valuation
📅 in about 1 hour

Tencent (HK:0700) in Talks to Become Largest Shareholder in AI Startup Manus at $2 Billion Valuation

Tencent is reportedly in discussions for a deal that would make it the largest shareholder in AI startup Manus, which is valued at roughly $2 billion. The talks have attracted attention as major technology companies continue to invest more in artificial intelligence while competition across the sector grows. If the deal goes ahead, Tencent would…

Read more 12
Gold Climbs to $4,143 as Iran Tensions Stoke Rate-Hike Fears—July 10
📅 in 40 minutes

Gold Climbs to $4,143 as Iran Tensions Stoke Rate-Hike Fears—July 10

Gold spot price climbs to $4,143.59 on July 10 as U.S.-Iran military escalation fuels inflation and rate-hike bets. Physical demand holds firm despite Fed pressure.

Read more 12
Kalyan Jewellers Rallies 34% in Three Days After Citi’s ₹750 Target—July 10
📅 30 minutes ago

Kalyan Jewellers Rallies 34% in Three Days After Citi’s ₹750 Target—July 10

Kalyan Jewellers stock jumps 34% in three days after Citi maintains ₹750 target. Q1 revenue grew 38% YoY. Market cap gained ₹11,500 crore. Investors now betting on long-term growth story.

Read more 12
Nikkei 225 Rises 1.20% to 68,557 as U.S. Semiconductor Rally Offsets ETF Redemption Selling
📅 1 hour ago

Nikkei 225 Rises 1.20% to 68,557 as U.S. Semiconductor Rally Offsets ETF Redemption Selling

On July 10, 2026, Japan’s Nikkei 225 climbed 1.20% to 68,557 after another strong session for U.S. semiconductor stocks lifted sentiment across Asian markets. Chipmakers drove most of the gains as Wall Street’s technology rally continued on growing demand for artificial intelligence. Even so, ETF redemption-related selling trimmed part of the market’s early advance. Below…

Read more 12
Apollo Global (NYSE: APO) to Acquire easyJet (LON: EZJ) in £5.7 Billion ($7.7 Billion) Deal
📅 1 hour ago

Apollo Global (NYSE: APO) to Acquire easyJet (LON: EZJ) in £5.7 Billion ($7.7 Billion) Deal

Apollo Global has agreed in principle to acquire easyJet for £5.7 billion. The deal values the UK budget carrier at £7.15 per share, roughly $7.65 billion in total. Apollo Global’s offer beats a rival £6.90 per share bid from Castlelake, agreed just five days earlier. EasyJet shares jumped as much as 15% on July 10,…

Read more 12
AstraZeneca Shares Plunge 7.4% After Heart Drug Trial Fails—July 10
📅 2 hours ago

AstraZeneca Shares Plunge 7.4% After Heart Drug Trial Fails—July 10

AstraZeneca stock fell 7.4% after Wainua heart drug trial missed primary goal. Jefferies models $2.5B sales loss. Meyka grades AZN B+, forecasts $131.71 by year-end.

Read more 12

GAVA News FAQ